Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015:2015:842817.
doi: 10.1155/2015/842817. Epub 2015 Oct 5.

Ketamine, Transcranial Magnetic Stimulation, and Depression Specific Yoga and Mindfulness Based Cognitive Therapy in Management of Treatment Resistant Depression: Review and Some Data on Efficacy

Basant Pradhan  1 , Tapan Parikh  2 , Ramkrishna Makani  2 , Madhusmita Sahoo  2
Affiliations
Review

Ketamine, Transcranial Magnetic Stimulation, and Depression Specific Yoga and Mindfulness Based Cognitive Therapy in Management of Treatment Resistant Depression: Review and Some Data on Efficacy

Basant Pradhan et al. Depress Res Treat. 2015.

Abstract

Depression affects about 121 million people worldwide and prevalence of major depressive disorder (MDD) in US adults is 6.4%. Treatment resistant depression (TRD) accounts for approximately 12-20% of all depression patients and costs $29-$48 billion annually. Ketamine and repetitive transcranial magnetic stimulation (rTMS) have useful roles in TRD, but their utility in long term is unknown. As per the latest literature, the interventions using Yoga and meditation including the mindfulness based cognitive therapy (MBCT) have been useful in treatment of depression and relapse prevention. We present a review of rTMS, ketamine, and MBCT and also report efficacy of a depression specific, innovative, and translational model of Yoga and mindfulness based cognitive therapy (DepS Y-MBCT), developed by the first author. DepS Y-MBCT as an adjunctive treatment successfully ameliorated TRD symptoms in 27/32 patients in an open label pilot trial in TRD patients. Considering the limitations of existing treatment options, including those of ketamine and rTMS when used as the sole modality of treatment, we suggest a "tiered approach for TRD" by combining ketamine and rTMS (alone or along with antidepressants) for rapid remission of acute depression symptoms and to use DepS Y-MBCT for maintaining remission and preventing relapse.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Depression specific Yoga and mindfulness based cognitive therapy (DepS Y-MBCT) model.
See this image and copyright information in PMC

References

    1. Kavalali E. T., Monteggia L. M. Synaptic mechanisms underlying rapid antidepressant action of ketamine. American Journal of Psychiatry. 2012;169(11):1150–1156. doi: 10.1176/appi.ajp.2012.12040531. - DOI - PubMed
    1. McIntyre R. S., Filteau M.-J., Martin L., et al. Treatment-resistant depression: definitions, review of the evidence, and algorithmic approach. Journal of Affective Disorders. 2014;156:1–7. doi: 10.1016/j.jad.2013.10.043. - DOI - PubMed
    1. Mrazek D. A., Hornberger J. C., Altar C. A., Degtiar I. A review of the clinical, economic, and societal burden of treatment-resistant depression: 1996–2013. Psychiatric Services. 2014;65(8):977–987. doi: 10.1176/appi.ps.201300059. - DOI - PubMed
    1. Zarate C., Duman R. S., Liu G., Sartori S., Quiroz J., Murck H. New paradigms for treatment-resistant depression. Annals of the New York Academy of Sciences. 2013;1292(1):21–31. doi: 10.1111/nyas.12223. - DOI - PMC - PubMed
    1. Ruhé H. G., Huyser J., Swinkels J. A., Schene A. H. Switching antidepressants after a first selective serotonin reuptake inhibitor in major depressive disorder: a systematic review. Journal of Clinical Psychiatry. 2006;67(12):1836–1855. doi: 10.4088/jcp.v67n1203. - DOI - PubMed

LinkOut - more resources